RSI společnosti SinoMab BioScience
Jaká je hodnota metriky RSI společnosti SinoMab BioScience?
Hodnota metriky RSI společnosti SinoMab BioScience Limited je 28.14
Jaká je definice metriky RSI?
Index relativní síly (Relative strength index - RSI 14) je technický ukazatel, který se řadí mezi momentum indikátory a měří rychlost a změnu ceny. Jeho hodnota se pohybuje mezi 0 a 100 a používá se k charakterizování překupovaného a přeprodaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI společností v sektoru Health Care sektor na HKSE ve srovnání se společností SinoMab BioScience
Čemu se věnuje společnost SinoMab BioScience?
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
Firmy s metrikou rsi podobnou společnosti SinoMab BioScience
- Hodnota metriky RSI společnosti Polished.com Inc je 28.11
- Hodnota metriky RSI společnosti Re:NewCell AB (publ) je 28.12
- Hodnota metriky RSI společnosti TechnipFMC plc je 28.12
- Hodnota metriky RSI společnosti Raj Television Network je 28.12
- Hodnota metriky RSI společnosti mutares AG je 28.13
- Hodnota metriky RSI společnosti Wai Hung je 28.13
- Hodnota metriky RSI společnosti SinoMab BioScience je 28.14
- Hodnota metriky RSI společnosti Devon je 28.15
- Hodnota metriky RSI společnosti UBS ETF (CH) - Palladium je 28.15
- Hodnota metriky RSI společnosti Manolete Partners Plc je 28.16
- Hodnota metriky RSI společnosti OptimizeRx je 28.16
- Hodnota metriky RSI společnosti Chevron je 28.16
- Hodnota metriky RSI společnosti Continental AG je 28.17